Amgen profits hit $5B, beat expectations
The biotech company recorded earnings per share of $7.60, well above the $7.46 expected by a survey of 27 analysts by Thomson Reuters.
Dry weather plagues Ventura County strawberries
Oxnard strawberry growers lost an average $10,000 to $15,000 per acre worth of crop last year because the berries died off prematurely in dry weather, and farmers could be in for a repeat of that scenario this year.
Ceres files for $20M offering
The Thousand Oaks-based firm said it would like to use the proceeds from the public offering to expand its Brazilian operations, participate in collaborations and break into new markets.
$98M office campus sale sets new high-water mark for county
The eye-popping price signals that a turnaround is taking hold in the Ventura County office market, which has suffered from high vacancy rates in a depressed job market, industry insiders say.
Amgen reports positive trial results for high-cholesterol treatment
The portion of Amgen’s Phase 3 trial of evolocumab that evaluated patients with high cholesterol who cannot tolerate statins has met goals related to percent reduction of low-density lipoprotein cholesterol.
Teledyne shares dip despite jump in Q4 profits
Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
